Evidence map›Paper›PMID 41998667›Full record

ArticleBMC complementary medicine and therapies2026

Dietary and non-dietary complementary and alternative medicine use in Saudi Arabia: the differential role of associated factors.

Omar B Da'ar, Mohammad Alkaiyat, Faisal A Alsadoun, Sarah G M Alshehri, Anadel H Hakeem, Hend R Almazroa, Manair N A Alrajhi, Fatemah S Bin Saleh, Abdulaziz A Almusalam, Nawaf Algannas and 3 more

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Omar B Da'arDepartment of Health Systems Management, College of Public Health & Health Informatics, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia. obdaar@gmail.com.ORCID http://orcid.org/0000-0002-2153-8761
Mohammad AlkaiyatDepartment of Health Systems Management, College of Public Health & Health Informatics, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0003-3500-6050
Faisal A AlsadounKing Faisal specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Sarah G M AlshehriMinistry of National Guard Health Affairs, King Abdulaziz Medical City, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia.
Anadel H HakeemMinistry of National Guard Health Affairs, King Abdulaziz Medical City, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia.
Hend R AlmazroaDepartment of Family Medicine, Security Forces Hospital, Riyadh, Kingdom of Saudi Arabia.
Manair N A AlrajhiOtorhinolaryngology Head and Neck Surgery Department, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
Fatemah S Bin SalehMinistry of National Guard Health Affairs, King Abdulaziz Medical City, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia.
Abdulaziz A AlmusalamDepartment of Family Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Nawaf AlgannasKing Fahad Medical City, Riyadh, Saudi Arabia.
Fahad Nasser AlzaidFamily Medicine Registrar at First Health Cluster, Riyadh, Saudi Arabia.
Abdullah E AlmaneaMinistry of National Guard Health Affairs, King Abdulaziz Medical City, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia.
Abdul Rahman JaziehCincinnati Cancer Advisors, Cincinnati, OH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionComplementary and alternative medicine (CAM) is widely used among cancer patients in Saudi Arabia. However, there is currently a lack of analysis of disaggregated data on CAM use. This study predicts the likelihood of CAM use, particularly dietary or non-dietary supplements, based on patients’ socioeconomic characteristics, clinical conditions, and motivations for use. A clearer understanding of these dynamics will enable healthcare providers to align evidence-based guidance with patients’ preferences and needs.

methodsThis cross-sectional study was conducted in oncology departments to investigate the use of CAM, both dietary and non-dietary supplements, among cancer patients. We utilized validated instruments to record specific therapies and non-mainstream practices that patients used. Descriptive statistics were applied to summarize the variables of interest, while we categorized CAM usage into dietary and non-dietary supplements. Multivariate logistic regression was performed to explore the association between CAM use, demographic, socioeconomic factors, clinical profiles, and motivations or reasons for use, while examining whether educational attainment moderates the influence of social beliefs and gender on CAM use.

resultsMore than three-quarters (79%) of patients reported CAM use; 69% used dietary supplements, 71% used non-dietary supplements, and 62.5% used both. Patients with intermediate or secondary education were about twice as likely to use dietary and non-dietary supplements concurrently as those without formal education (OR = 2.15, 95% CI, 1.04-4.46, p = 0.04). By contrast, monthly income > $1,600 (vs. < $800) and having a hematologic malignancy were associated with lower odds of concurrently using dietary and non-dietary supplement use (OR = 0.58, 95% CI, 0.35-0.98, p = 0.04 & OR = 0.58, 95% CI, 0.35-0.98, p = 0.03). Women were twice as likely as men to use dietary supplements (OR = 2.17, 95% CI, 1.16-4.08, p = 0.02). Mood improvement was a strong motivator, where patients reporting this reason were more likely to use dietary supplements (OR = 2.67, 95% CI 1.26-5.66, p = 0.01) or non-dietary supplements (OR = 2.40, 95% CI 1.04-5.53, p = 0.04). Patients aged >50 years were less likely to use non-dietary supplements than younger patients (OR = 0.39, 95% CI, 0.17-0.90, p = 0.03). Educational attainment did not moderate the influence of social beliefs and gender on CAM use.

conclusionCAM use was highly prevalent and significantly predicted by socioeconomic factors, clinical profiles, and mood improvement as a motivation for use. There is a need for integrating proactive CAM use screening that addresses gender , age , and diagnosis specific patterns of CAM use and risks. Future studies that investigate patients’ decision-making and evaluate the safety and efficacy of commonly and locally used CAM supplements.

Indexed as

Complementary TherapiesDietary SupplementsNeoplasmsAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedSaudi ArabiaSocioeconomic FactorsYoung AdultCancer patientsComplementary and alternative medicine useDietary supplementsNon-dietary supplementsSaudi Arabia

Identifiers

PMID41998667
PMCPMC13220418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.